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 The present study was undertaken to assess the cardiopul-
monary response during the initial period of exercise at a 
low workload in 8 patients with COPD and 10 normal sub-
jects. In the patients with COPD VO2/VE and VCO2/VE were 
significantly lower than in the normal controls, and more 
markedly so during the initial period of exercise. SaO2 and Sv 
O2 decreased dramatically in the initial period of exercise in 
the COPD compared with the normal subjects. In contrast to 
the normal subjects, pulmonary artery mean pressure 
(PAMP) increased substantially during the initial period of 
exercise in the patients with COPD. These findings imply that 
blood gas changes on exercise can be explained by the 
differences in the relative increase of VO2, VCO2, VE and 
cardiac output. Our study also suggests that the measure-
ment of VO2/VE, VCO2/VE and SvO2 and PAMP on exercise at 
a low workload, especially during the initial period, may be 
useful for evaluating the cardiopulmonary response to COPD 
patients.
Introduction 
 Cardiopulmonary exercise testing can help to determine 
where lies the factor limiting the exercise in the lungs, the 
heart, or in both organs. Although the basic physiologic 
response to exercise has been studied extensively, there are 
still several controversies regarding the cardiopulmonary 
response to exercise in patients with chronic pulmonary 
disease including COPD. The present study was undertaken 
to assess the cardiopulmonary response to exercise at a 
low work load in patients with COPD and normal indi-
viduals. We concentrated on the response in the initial 
period of exercise to investigate whether or not it could be 
used to distinguish COPD patients from normal subjects. 
Method 
 Eight patients with COPD and 10 normal individuals 
were studied. The clinical characteristics of both groups 
are presented in Table 1. All 8 patients with pulmonary 
disease had a clinical course consistent with COPD and 
none of them had clinical or radiographic evidence of 
cardiac disease.
 An arterial catheter was inserted into the radial artery 
and balloon-tipped thermal dilution cardiac output cathe-
ter was inserted into a subclavicular vein and advanced to 
the pulmonary under fluoroscopic visualization and 
pressure recording. Cardiac output (CO) was measured at 
rest as well as after 3 min. and 15 min. of exercise. Arterial 
and mixed venous blood gases were measured at rest and 
during exercise using an ABL3 automated blood gas 
machine. The 02 saturation in arterial and mixed venous 
blood was measured continuously by pulse oximetry 
(Edwards Critical Care Explorer Mode (EXP-N)). The 
values of AaD02i VD/VT, 02 Extra, 02-transport (02T) 
and overall VA/Q were calculated using standard formu-
las. Expired gas was analyzed with an expired gas analyzer 
(Medical Gas Analyzer MG-360). Using this gas analyzer, 
a printout was produced at 15-sec intervals of the follow-
ing parameters ; ventilation /min.(VE), oxygen uptake (V 
02), carbon dioxide production (VC02), the respiratory 
gas exchange ratio(R)s and other calculated parameters 
such as V02/VE and VC02/VE. Exercise testing was 
performed on a electrically braked bicycle ergometer at a 
constant load of 35 W for 15 min. 
 Data are expressed as the mean and standard deviation. 
The unpaired t-test was used to compare variables between 
groups, and the paired t-test was used to compare vari-
ables within the same group. Differences were accepted as 
significant at p <0.05.
Table 1 Clinical profile of the normal subjects and the 
COPD patients
               Normal subjects COPD 
                  (n =10) (n =8) 
Age (yrs) 63.7±7.7 65.0±4.6 
%VC (%) 99.5±26.5 95.1±22.6 
FEV i.o% (%) 73.2±14.2 45.1±11.6 
%DLco (%) 81.8±24.6 46.6±17.4 
Pa02 (Torr) 89.7±10.9 71.6±14.9 
PaC02 (Torr) 32.6±3.6 36.2±5.4 
pHa 7.384±0.034 7.377±0.016 
PAMP (mmHg) 13.1±2.1 19.9±6.6 
CO (L/min) 5.27±1.79 4.42±0.88
Results 
 Table 2 summarizes the mean values at the gas exchange 
variables at rest and on exercise. There were no significant 
differences in V02 and VCO2 between the 2 groups at rest or 
during exercise. VE was higher at rest and the difference 
became more marked during early exercise in the patients 
with COPD compared with the normal subjects. However, 
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V02/VE and VCO2/VE were higher in the normal subjects 
than in the COPD patients, and the difference was promi-
nent after 1 min and 2 min of exercise (p = 0.0146 and p = 
0.0175, respectively) (Figs.1 and 2). R values were higher 
in the COPD patients both at rest and during exercise. 
 Table 3 summarizes the mean values of the arterial and 
mixed venous blood gas data. The patients with COPD 
showed mild hypoxemia (PaO2 = 71.6 ± 14.9 mmHg) at 
rest and a further decrease in PaO2 (65.9 ± 15.5 mmHg) 
during exercise. In normal individuals, Pa02 increased 
slightly from 89.7 ± 10.9 mmHg at rest to 95.4 ± 12.6 
mmHg after exercise. In the patients with COPD, PaCO2 
showed a tendency to increase from 36.2 ± 5.4 mmHg at 
rest to 39.0 ± 9.7 mmHg after exercise. In contrast, the 
normal subjects showed no changes in PaCO2 between rest 
and exercise. Normal subjects had a significantly higher Pv 
02 than the COPD patients both at rest and after exercise 
(p = 0.0249 and p = 0.0040, respectively), while PvCO2 
tended to be higher in the COPD patients both at rest and 
after exercise. In addition, AaDO2 was higher in the
Fig. 1 Changes of V02/VE during exercise
Fig. 2 Changes of VCO2/VE during exercise
                           Table 2 Changes of gas exchange parameters during exercise 
                rest 1min 2min 3min 4min 5min 6min 15min 
  V02 NR 211.3±40.3 301.9±73.4 442.5±80.4 476.2±68.6 468.2±89.7 497.5±84.5 476.4±76.9 500.8±90.4 
of/min COPD 213.0±27.7 327.9±62.7 401.4±76.8 455.1±107.1 469.1±102.4 472.6±106.1 459.4±127.5 522.2±134.1 
 VCO2 NR 170.7±36.1 242.4±48.8 354.0±78.6 404.4±68.2 415.7±64.2 455.8±97.4 441.6±83.5 459.0±100.1 
mQ/min COPD 173.0±20.4 277.9±99.9 331.9±48.8 392.1±86.6 418.9±85.3 444.6±84.0 436.3±115.8 496.8±136.7 
   R NR 0.81±0.08 0.81±0.10 0.80±0.08 0.85±0.10 0.90±0.10 0.91±0.12 0.93±0.09 0.91±0.10 
      COPD 0.82±0.07 0.83±0.13 0.84±0.12 0.87±0.09 0.90±0.07 0.95±0.09 0.96±0.05 0.95±0.05 
  VE NR 8.65±1.67 11.12±2.60 14.59±3.87 16.14±2.64 16.84±3.44 18.27±3.85 17.99±2.98 19.12±3.58 
L/min COPD 10.11±1.56 15.22±4.91 16.76±4.00 19.19±5.79 19.94±5.97 21.00±6.41 21.07±7.26 23.99± 7.09 
V02/VE NR 24.8±2.9 27.5±3.6 31.4±5.4 30.0±5.3 28.3±4.9 27.7±3.7 26.8±4.4 26.4±3.2 
W L COPD 21.2±3.9 22.7±3.6 24.5±5.1 24.4±5.8 24.4±5.1 23.4±6.7 22.4±5.4 22.1±5.2 
V02/VE NR 20.0±2.5 22.0±2.9 24.7±2.8 25.3±3.3 25.0±2.9 25.0±3.1 24.7±3.9 24.1±3.2 
mQ/L COPD 17.1±2.0 18.4±1.7 20.2±3.1 21.0±3.5 21.7±3.4 22.2±5.6 21.4±4.3 21.3±5.2
         Table 3 Mean arterial and mixed venous blood gases in normal subjects and COPD patients 
                         Normal subject (n = 10) COPD (n = 9)
                          Rest Exercise Rest Exercise
pHv 7.384±0.034 7.329±0.019 7.377±0.016 7.306±0.037 
PvC02 (Torr) 37.3±5.3 42.4±4.6 41.1±6.2 47.5±8.7 
Pv02 (Torr) 40.7±5.0 33.6±2.9 35.9±2.6 28.7±3.1 
pHa 7.402±0.024 7.372±0.015 7.399±0.024 7.364±0.047 
PaCO2 (Tory) 32.6±3.6 33.2±1.9 36.2±5.4 39.0±9.7 
Pa02 89.7±10.9 95.4±12.6 71.6±14.9 65.9±15.5        (Torr) 18.2±12.0 16.8±10.8 33.8±14.1 40.2±13.1 AaD02 (Torr) 0.42±0.09 0.35±0.09 0.54±0.03 0.48±0.07 
VD/V1 0.72±0.48 1.30±0.27 0.70±0.21 1.36±0.51 V 
A/Q 0.2239±0.0992 0.3840±0.0609 0.2566 ±0.0359 0.4694±0.0525 
O2Extra 48.7±17.2 63.0±20.6 40.4±5.1 59.7±8.9
 patients with COPD than the normal subjects both at 
rest (p = 0.0256) and after exercise (p = 0.0011). In the 
COPD patients, AaDO2 tended to increase on exercise to 4 
0.22 ± 13.09 mmHg from 33.83 ± 14.11 mmHg. However, the 
normal subjects showed a decrease of AaDO2 after exercise 
compared with at rest (16.81 ± 10.79 mmHg vs. 18.16 ± 
11.97 mmHg). VD/VT was significantly higher in the 
COPD patients than the normal subjects both at rest (p = 
0.0036) and after exercise (p = 0.0046), but VD/VT tended 
to decrease after exercise in both groups. Overall VA/Q 
increased significantly in both the COPD patients and the 
normal subjects from rest to exercise, and there was no 
difference between the 2 groups. In the COPD patients, 02 
Extra was higher at rest and significantly so after exercise 
(p = 0.0078) when compared with the normal subjects. 
 The SaO2 and SV02 values measured by pulse oximetry 
are shown in Fig.3. In normal subjects, Sa02 showed 
almost no changes, but it decreased in the COPD patients 
during exercise and showed the most rapid decline during 
the first 2 min. Sa02 decreased from 95.6±3.3% at rest to 
91.8±8.8% after 2 min of exercise. SV02 was much higher 
in the normal subjects than the COPD patients both at rest 
(77.10 ± 4.25% vs 70.50 ± 3.63%, p = 0.0031) and after 
exercise (59.38±7.85% vs 50.50±6.80%, p = 0.00336). Sv 
02 decreased significantly in both the COPD patients and 
the normal subjects from rest to exercise and the largest 
decline occurred in the initial period of exercise. However, 
in normal subjects there was no further decrease of SV02 
after 1 min of exercise while it continued to fall until 3 min 
in the COPD patients. 
 Figures 4 and 5 show the changes of hemodynamic 
variables during exercise. CO tended to be lower in the 
patients with COPD (4.4±0.9 L/min.) than in the normal 
subjects (5.3 ± 1.8 L/min.) at rest. It increased signifi-
cantly in both groups during exercise. However, the normal 
subjects had a higher CO after 3 min at the end of exercise, 
while the patients with COPD had a higher CO at the end 
of exercise (Fig.4). Thus, CO increased more slowly in
Fig. 4 Changes of CO during exercise
Fig. 5 Changes of PAMP during exercise
COPD. PAMP in patients with COPD showed a higher 
value both at rest and during exercise than that of normal 
subjects. In the COPD patients, PAMP increased rapidly 
during the first 3 min of exercise from 19.9±6.6 mmHg to 
32.6 ± 14.0 mmHg (p = 0.0116). In contrast, the normal 
subjects showed no significant change of PAMP with 
exercise (Fig.5).
Fig. 3 Changes of Sao, and Sv0 2 during exercise
Discussion 
 This study showed that there were no significant differ-
ences in V02 and VCO2 between the COPD patients and the 
normal control subjects both at rest and during exercise. 
However V02/VE and VCO2/VE were significantly higher 
in the normal subjects than in the COPD and the difference 
was greatest at the initial period of exercise. Thus, COPD 
patients had a higher VE than the normal subjects. It has 
been shown that COPD patients exhibit a high ventilatory 
response at any level of oxygen uptake during exercise (1), 
which implies that alveolar ventilation does not show as 
great a relative increase as VO2 and VCO2 when compared 
with normal subjects. Although VE is higher (hyperventi-
lation) in COPD patients than normal subjects because of 
poor gas exchange, VE cannot counterbalance the
increment of VO2 and VC02 on exercise, and this seems to 
be more of a problem in the initial period of exercise. 
Accordingly, the values of VO2/VE and VCO2/VE were 
lower in COPD patients than in normal subjects. 
Inefficient gas exchange is reflected by the pulmonary 
function data at rest, as well as by AaDO2 and VD/VT at 
rest and on exercise. Since alveolar ventilation cannot 
• increase relatively as much as V02 and Vco2 during exercise 
in COPD, both PaO2 and SaO2 must fall and PaCO2 tends to 
rise. However, the overall VA/Q relationship seems to be 
improved after exercise in patients with COPD and showed 
no significant difference from that in the normal subjects. 
Similar findings have been previously reported by others 
(2)(3). Gledhill and coworkers (3) pointed out the importance 
of an increase in mean VA/Q (caused by a greater increase 
of ventilation than cardiac output during exercise) for 
preserving a normal Pa02 despite the increased VA/Q 
inbalance and decreased PvO2. Because the Pv02 influences 
the end-capillary PO, of every lung unit (4), one might 
expect that exercise would lead to a fall in Pa02. However, 
as VA/Q increases above 1.0, the impact of a falling Pv 
02 on end-capillary P02 diminishes (5) and significant 
arterial desaturation is prevented. In the patients with 
COPD, AaDO2 and VD/VT were significantly higher than 
in the normal subjects both at rest and after exercise 
suggesting that pulmonary 02 transfer may be partially 
limited by diffusion in COPD. In addition, R tended to 
increase and Pv02 to decrease during exercise, which could 
be - nother causes of an increase in AaDO2 in COPD. (6) . 
Further studies are needed to confirm these observations. 
 Our results showed that both Pv02 and Sv02 fell dra-
matically in the COPD patients and more obviously in the 
initial 3 min of exercise. As is well known, two mecha-
nisms furnish oxygen to working muscles during exercise, 
with one being an incr case in muscle blood flow and the 
other being an increase in f issue oxygen extraction. Even in 
normal subjects, PvO2 and S%_02 fall with exercise, because 
the ralative increase in VO2 exceeds that of the cardiac 
output (6). Our results showed that PvO2 and SvO2 fell 
while 02 Extra increased during exerci;,e in both the COPD 
patients and the normal subjects. However, the patients 
with COPD showed more substantial decrease; of Sv02, PV 
02 and a greater increase of 02 Extra than that of normal 
subjects, even with modest exercise. This suggests that the 
patients with COPD have pulmonary hypertension due to 
hypoxic vasoconstriction compounded by structural.
abnormalities. Thus, the cardiac output response to 
exercise may be subnormal or abnormal, so that SvO2 
along with Pv02 is lower than in normal subjects. As our 
results showed, patient with COPD tended to have a lower 
CO than the normal subjects and this difference was more 
obvious in the initial period of exercise (up to 3 min). The 
COPD patients also showed a significant increase of 
PAMP that was marked during early exercise and appeared 
to be consistent with the changes of CO. Pulmonary 
hypertension limits the degree to which CO can be in-
creased as a method of increasing tissue oxygen delivery 
(7). 
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 In conclusion, our data indicate that VO2/VE and VCO2/ 
VE are significantly lower in COPD than in normal 
controls and are more significantly so at the initial period 
of exercise. In the patients with COPD, Sa02 and SvO2 were 
significantly lower than in the normal subjects, and more 
substantially so in the initial period of exercise. In COPD 
patients, PAMP was also significantly increased during 
early exercise when compared with normal subjects. These 
findings imply that the blood gas changes on exercise can 
be explained by differences in the relative increase of VO2, 
VCO2, VE, and cardiac output. Our results suggest that 
                                   e e 
the measurement of VO2/VE. VCO2/VE, SvO2, and PAMP 
on exercise, especially in the initial period at a relatively 
low workload, may be useful for evaluating the cardiopul-
monary response to exercise in patients with COPD.
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